Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | MANBA | O00462 | 1/20 | 0.32 |
| ▸ | IDUA | P35475 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | GUSB | P08236 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2931003 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL813413 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL2466059 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL4444890 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL468717 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL2466054 | 1.00 | LMNA (0.35) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL15858 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL6669482 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL592850 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA | |
| SCHEMBL15630 | 0.95 | LMNA (0.40) | LMNAGBA1DNMT1CTDSP1MANBA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110996886-B | Hair composition for wound treatment | 联合利华知识产权控股有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-113651803-B | Process for producing diphenylmethane derivative | 株式会社大熊制药 | 2022-10-28 | — | — | CN | disclosed |
| CN-113651803-A | Process for producing diphenylmethane derivative | 株式会社大熊制药 | 2021-11-16 | — | — | CN | disclosed |
| CN-109311861-B | Process for producing diphenylmethane derivative | 株式会社大熊制药 | 2021-08-24 | — | — | CN | disclosed |
| CN-112367987-A | Active agents and methods for their use in treating metabolic disorders and non-alcoholic fatty liver disease | 旗舰创业创新五公司 | 2021-02-12 | — | — | CN | disclosed |
| EP-3394284-B1 | ENZYMATIC METHOD FOR THE EVALUATION OF XYLOSE | VENTER PHARMA S L (ES) | 2020-02-12 | — | — | EP | disclosed |